Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-458246

Co-Chief Executive Officer sold 100,000 shares at an average $29.84 ($2,983,838)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klee Justin B. Co-Chief Executive Officer 2026-11-09 Sale 10b5-1 −37,483 $29.39 $1,101,689 3,575,573 D
Klee Justin B. Co-Chief Executive Officer 2026-11-09 Sale 10b5-1 −62,517 $30.11 $1,882,149 3,513,056 D
Open-market sales · 100,000 sh · avg $29.84 · $2,983,838
Loading xslF345X06/ownership.xml…